Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32K Sell
72
-93
-56% -$1.99K ﹤0.01% 1187
2026
Q1
$3.33K Buy
165
+66
+67% +$1.47K ﹤0.01% 744
2025
Q4
$1.9K Hold
99
– – ﹤0.01% 811
2025
Q3
$2.38K Hold
99
– – ﹤0.01% 612
2025
Q2
$1.93K Buy
+99
New +$1.46K ﹤0.01% 625

Other funds holding ADNT

Kilter Group's ADNT Position: Q2 2026 in Review

Kilter Group reduced its Adient (ADNT) stake by 56% in Q2 2026, selling an estimated $1.99K and leaving 72 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

Kilter Group first reported a position in ADNT in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.33K in Q1 2026. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Kilter Group held 72 shares of Adient worth $1.32K as of Q2 2026.
  • Kilter Group sold 93 Adient shares in Q2 2026, an estimated $1.99K.
  • Adient made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #1187 holding.
  • Kilter Group first reported a position in Adient in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Adient position peaked at $3.33K in Q1 2026.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.